Please assess the completion status of the following clinical trial:

Trial Title: Effect of Probiotics on Recurrent Urinary Tract Infections

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women over 18 years of age.~* Women who have had at least one episode of UTI in the past 2 months~* Women with a well-documented history of recurrent UTIs: ≥2 infections in the past 6 months or ≥3 in the past 12 months.~* Women who have been treated with an antibiotic regimen for each episde of UTI~* Recurrence due to reinfection, not relapse: multiple infections should be spaced by a minimum of 2 weeks or in case of a shorter time, with negative urine culture between them~* Women who use contraception to prevent pregnancy and who do not plan a pregnancy during the study period~Exclusion Criteria:~* Pregnant or breastfeeding women~* Underlying chronic disease: diabetes mellitus, kidney failure, cancer, spinal cord injury, polycystic ovary~* Women wih catheters in the urethra~* Women who consume probiotics or foods, beverages or supplements containing extracts or parts of the genus Vaccinum sp, including other forms of V. macrocarpon (blueberry), V. myrtillus (European blueberry), V. angustifolium (wild or low buch blueberry), V. corymbosum (tall bch blueberry) or V. vitis-ideae (mountain blueberry) during the 2 weels prior to recruitment.~* High consumption of fruits rich in phenolic compounds, with special reference, to berries~* Women allergic to red fruits~* BMI ≥ 40 Kg/m2

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Experimental (Type: EXPERIMENTAL): Probiotic formulation comprising Lactobacillus plantarum CECT8675 and CECT8677 in combination with cranberry, and vitamine C in a capsule format. Probiotic strains have Qualified Presumption of Safety (QPS) sttus by European Food Safety Authority.
- Placebo (Type: PLACEBO_COMPARATOR): Placebo composed of maltodextrin

Based on this trial design, predict the completion outcome and termination type (if applicable).